Surgeon and nurse around the da Vinci Robot in a surgery room
Surgeons Capable Of

The Highest Level of Performance

The Global Robotics Institute has a dedicated team focused on academia and learning. Thanks to our comprehensive research team and robust fellowship program, we continue to pave the way for new advancements in urologic oncology.

The research team at the Global Robotics Institute is committed to practicing evidence-based medicine. Our team has been published in multiple international journals and has authored several landmark articles in the field of urologic oncology. Learn more about our research team’s projects and trials here.

Our fellowship program focuses on both personal and professional development that ensures appropriate and safe patient care. The Global Robotics Institute fellowship program emphasizes a high-level focus on both surgery and research. The goal of our program is to produce a robotically-trained surgeon who is capable of a high level of performance. If you are a physician in training interested in our program, you can learn more here.

Together, da Vinci® surgery technology and your doctor have the ability to perform complex procedures through just a few small openings.
The GRI Clinical Fellowship team posing in a group on some stairs

Clinical Fellowships Program

The Global Robotics Institute is fully committed to developing bright urology residents with an interest in pursuing a career in urologic oncology. Located on the AdventHealth Celebration Health campus in a leading-edge environment, the 12- and 24-month fellowships provide excellent educational experiences.  Fellowships begin on July 1 each year and provide a valuable educational experience that will result in peer-reviewed publications. You'll learn from one of the most advanced teams in the field as you continue your path into a urologic oncology specialty or sub-specialty.

Research and Clinical Trials

If research is the lifeblood of medicine, clinical trials are its heart. Together, they drive medicine forward and are behind all new medical advances and techniques.

Global Robotics Institute (GRI) is fully committed to this ideal. Yet, it only scratches the surface of why we maintain a staff of some of best physicians, clinicians and research specialists in the world. By tackling complex medical issues, we learn for ourselves why they exist and how we can move step-by-step closer to solving them. It also provides valuable insight into diseases and treatments. This enables us to ethically counsel patients about the goals and limits of treatments they may be considering.

We do not do this alone. We are among the world’s most experienced medical researchers, so it is our duty to also share the things we learn so that everyone may benefit. Clinical data collection, including comprehensive outcomes information, provides key information to help GRI and other medical institutes discover new medical breakthroughs.

In all of these important ways, our work at GRI supports the greater purpose of healing and enriching lives around the globe.

5 items. To interact with these items, press Control-Option-Shift-Right Arrow
The Purpose of Clinical Trials

Clinical trials are designed to look at new ways to prevent, detect or treat disease. Our goal is to determine if a new test or treatment works and is safe. But they also look at other aspects of care, such as improving the quality of life for people suffering with chronic illness. In this important way, clinical trials can provide patients and their loved ones much-needed hope.

People join clinical trials for different reasons. Without their generosity, it would be almost impossible to enjoy the many medical advances we take for granted today. Healthy volunteers frequently say they participate to help others and to move science forward. Those with an illness or disease also participate to help others, but also to possibly receive the newest treatment and  additional care and attention from the clinical research staff.

Our Clinical Research Studies

GRI is a leading-edge medical treatment and research facility that conducts may types of studies. These include clinical trials. For instance, current studies include the use of blood, urine and prostate tumor tissue to develop more-sensitive testing techniques to help better treat and cure prostate cancer.

We also continually study and refine our surgical techniques to advance the field. Through our integrated database of over 7,000 robotic-assisted surgeries, we carefully track and record each outcome. This knowledge is then used to further improve our care to provide the best possible outcomes for our patients. 

Patient Follow-Up

Our research team is also fully committed to the post-operative care of patients to help ensure the best possible outcomes from treatment.

We understand that many patients follow up with a local urologist that is more conveniently located closer to their homes. So under the direction of Dr. Patel, each patient is called at several key, scheduled times following surgery: From six weeks through 18 months and then annually thereafter. Our goal is to monitor and record that patients are getting the recommended PSA tests and assess their quality of life after receiving a radical prostatectomy. This provides Dr. Patel information that helps him ensure the continued health of his patients.

Current Global Robotics Institute Studies

Urologic Robotic Surgery Outcomes Registry
Over 10,000 robotic radical prostatectomies are currently registered. This number keeps growing as we add more data to better track which types of surgery and treatments are leading to the best results over time.

The Following Studies are Closed to Enrollment:

Exosomes (cellular bodies) will be separated from collected study participants urine collection to look at specific molecules (RNA) and compare it to the features that are present in the prostatectomy and biopsy specimen.  Looking at these molecules will allow us to evaluate the progression of the disease and possibly develop a more precise laboratory test to detect the potential advancement of prostate cancer.

RNA Biomarker Discovery and Development for the Detection and Treatment of Prostate Cancer
Partnership study with Dr. Ranjan Perera at Sanford Burnham Medical Research Institute of Lake Nona, Florida.

The purpose of this study is to compare the effects (good and bad) of the combination of chemotherapy and hormone therapy followed by radical prostatectomy with radical prostatectomy alone.

Role of Obesity in Prostate Cancer Progression
Collaboration between AdventHealth Cancer Institute and Dr. Steven Smith that explores the hypothesized association between inflammation of adipose tissue (fat found just below the skin and surrounding organs) and prostate inflammation in humans, as well as the role of adipose tissue in the progression of prostate cancer.

A prospective randomized clinical trial using dehydrated human amnion/chorion membrane (dhacm) in nerve sparing robotic assisted laparoscopic radical prostatectomy (ralp) – effect on potency outcomes
The overall objective of this study is to evaluate the effectiveness of dehydrated human amnion/chorion membrane (dHACM) in reducing neurovascular bundle inflammation in prostate cancer patients undergoing bilateral full nerve sparing robotic assisted laparoscopic radical prostatectomy (RALP). Specifically, this study compares potency outcomes in patients who had full nerve sparing RALP procedures with dHACM application to the neurovascular bundles to that of full nerve sparing RALP without dHACM application to neurovascular bundles.

Medical Publications

2013 Medical Publications

  • Perioperative and early oncological outcomes after robot-assisted radical prostatectomy (RARP) in morbidly obese patients: a propensity score-matched study
    Abdul-Muhsin H, Giedelman C, Samavedi S, Schatloff O, Coelho R, Rocco B, Palmer K, Ebra G, Patel V. BJU Int. 2013 Mar 5. doi: 10.1111/j.1464-410X.2013.11798.x.
  • Salvage robot-assisted radical prostatectomy
    Haidar Abdul-Muhsin*, Srinivas Samavedi, Claudio Pereira, Kenneth Palmer, Vipul Patel. Article first published online: 2 APR 2013  DOI: 10.1111/bju.12073
  • Proposal of a method to assess and report the extent of residual neurovascular tissue present in radical prostatectomy specimens
    Oscar Schatloff1, Darian Kameh1,  Camilo Giedelman1, Srinivas Samavedi1, Haidar Abdul-Muhsin1, Rafael F. Coelho2, Sung Gu Kang3, Kenneth J. Palmer1, Vipul R. Patel1,* Article first published online: 19 APR 2013 DOI: 10.1111/bju.12038
  • Assessment of robotic simulation use in residency programs of the southeastern section of the American Urologic Association
    Thiel DD, Patel VR, Larson T, Lannen A, Leveillee RJ. Journal of Surgical Education 2013; 70(5): Accepted for publication 4/27/2013

2014 Medical Publications

  • The Tube 3 Module Designed for Practicing Vesicourethral Anastomosis in a Virtual Reality Robotic Simulator: Determination of Face, Content, and Construct Validity Sung Gu Kang, Seok Cho, Seok Ho Kang, Abdul Muhsin Haidar, Srinivas Samavedi, Kenneth J. Palmer, Vipul R. Patel, and Jun Cheon;

UROLOGY -: -e-, 2014. _ 2014 Elsevier Inc.

  • Long Noncoding RNAs as Putative Biomarkers for Prostate Cancer Detection

Bongyong Lee, Joseph Mazar, Muhammad N. Aftab, Feng Qi, John Shelley,              Jian-Liang Li, Subramaniam Govindarajan, Felipe Valerio,  Inoel Rivera, Tadzia Thurn, Tien Anh Tran, Darian Kameh,  Vipul Patel,  and Ranjan J. Perera  

Journal of Molecular Diagnostics, 2014, 16: 1e12;

  • Handling difficult anastomosis. Tips and tricks in obese patients and narrow pelvis Srinivas Samavedi, Haidar Abdul‑Muhsin, Suneel Pigilam, Ananth Sivaraman1,Vipul R. Patel Indian Journal of Urology, Oct-Dec 2014, Vol 30, Issue 4
  • PROSTATE CANCER Superior outcomes after a long learning curve with RARP

Vipul Patel and Srinivas Samavedi Nat. Rev. Urol. advance online publication 4 February 2014; doi:10.1038/nrurol.2014.10

  • Perioperative and early oncological outcomes after robot-assisted radical prostatectomy (RARP) in morbidly obese patients: a propensity score-matched study Haidar Abdul-Muhsin, Camilo Giedelman, Srinivas Samavedi, Oscar Schatloff, Rafael Coelho, Bernardo Rocco, Kenneth Palmer, George Ebra and Vipul Patel BJU Int 2014; 113: 84–91

2015 Medical Publications

  • Dehydrated Human Amniotic Membrane Allograft Nerve Wrap Around the Prostatic Neurovascular Bundle Accelerates Early Return to Continence and Potency Following Robot-assisted Radical Prostatectomy: Propensity Score–matched Analysis Vipul R. Patel *, Srinivas Samavedi, Anthony S. Bates, Anup Kumar, Rafael Coelho, Bernardo Rocco, Kenneth Palmer Eur Urol (2015),
  • Does surgeon subjective nerve sparing score predict recovery time of erectile function following robot-assisted radical prostatectomy? Kang SG, Schatloff O, Haidar AM, Samavedi S, Palmer KJ, Cheon J, Patel VR.J Sex Med. 2015 Jun;12(6):1490-6. doi: 10.1111/jsm.12844. Epub 2015 Feb 16. PMID: 25689342.
  • Current status of robotic simulators in acquisition of robotic surgical skills

Anup Kumara, Roger Smith, and Vipul R. Patel Curr Opin Urol 2015, 25:168–174

  • Age stratified comparative analysis of perioperative, functional and oncologic outcomes in patients after robot assisted radical prostatectomy - A propensity score matched study. Kumar A, Samavedi S, Bates AS, Cuevas CA, Coelho RF, Rocco B, Palmer K, Patel VR. Eur J Surg Oncol. 2015 Apr 25. pii: S0748-7983(15)00390-X. doi: 10.1016/j.ejso.2015.04.006. [Epub ahead of print]. PMID: 25980748.
  • Overall rate, location, and predictive factors for positive surgical margins after robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.

Kang SG, Schatloff O, Haidar AM, Samavedi S, Palmer KJ, Cheon J, Patel VR.Asian J Androl. 2015 May 5. doi: 10.4103/1008-682X.148723. [Epub ahead of print]. PMID: 25966623.

  • Continence outcomes of robot-assisted radical prostatectomy in patients with adverse urinary continence risk factors. Kumar A, Samavedi S, Bates AS, Coelho RF, Rocco B, Palmer K, Patel VR.BJU Int. 2015 Feb 26. doi: 10.1111/bju.13106. [Epub ahead of print] PMID:25726729.
  • Robot-assisted radical prostatectomy: recent advances. Mistretta FA, Grasso AA, Buffi N, Cozzi G, De Lorenzis E, Fiori C, Patel VR, Porpiglia F, Scarpa RM, Srinivas S, Rocco B Minerva Urol Nefrol. 2015 Jun 18 [Epub ahead of print]
  • V4-07 use of intra-operative indocyanine green and firefly® technology to visualize the “landmark artery” for nerve sparing robot assisted radical prostatectomy

Anup Kumar, Srinivas Samavedi, Anthony Bates, Rafael Coelho, Bernardo Rocco, Jeff Marquinez, Cathy Jenson, Kenneth Palmer, Vipul Patel

The Journal of Urology, April 2015 Volume 193, Issue 4, Supplement, Page e406

  • Safer Surgery by Learning from Complications: A Focus on Robotic Prostate Surgery

Rene´ J. Sotelo, *, Alexander Haese , Victor Machuca , Luis Medina , Luciano Nunez , Flavio Santinelli , Andres Hernandez, Ali Riza Kural , Alexander Mottrie  , Camilo Giedelman  , Mariano Mirandolino i , Kenneth Palmer j , Ronney Abaza, Reza Ghavamian , Arieh Shalhav, Alireza Moinzadeh , Vipul Patel  , Michael Stifelman  , Ingolf Tuerk  , David Canes 0302-2838/# 2015 European Association of Urology. Published by Elsevier B.V.

2016 Medical Publications

  • Overall rate, location, and predictive factors for positive surgical margins after robot‑assisted

laparoscopic radical prostatectomy for high‑risk prostate cancer

Sung Gu Kang, Oscar Schatloff, Abdul Muhsin Haidar2, Srinivas Samavedi, Kenneth J Palmer, Jun Cheon,Vipul R Patel

Asian Journal of Andrology (2016) 18, 123–128

  • Posterior musculofascial reconstruction after radical prostatectomy: an updated systematic review and a meta-analysis

A. A. C. Grasso , F. A. Mistretta, M. Sandri, G. Cozzi, E. De Lorenzis, M. Rosso, G. Albo, F. Palmisano, A. Mottrie, A. Haese, M. Graefen, R. Coelho, V. R. Patel and B. Rocco DOI: 10.1111/bju.13480 09March2016